U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
AZD-8895
Preferred Name English
TIXAGEVIMAB
INN   USAN  
Official Name English
tixagevimab [INN]
Common Name English
TIXAGEVIMAB [USAN]
Common Name English
AZD8895
Code English
COV2-2196
Code English
IMMUNOGLOBULIN G1 (240-THREONINE,241-METHIONINE,308-TYROSINE,310-THREONINE,312-GLUTAMIC ACID), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL AZD8895 .GAMMA.1-CHAIN), DISULFIDE WITH HUM
Common Name English
Tixagevimab [WHO-DD]
Common Name English
TIXAGEVIMAB [JAN]
Common Name English
Code System Code Type Description
NCI_THESAURUS
C177082
Created by admin on Wed Apr 02 08:53:30 GMT 2025 , Edited by admin on Wed Apr 02 08:53:30 GMT 2025
PRIMARY
DAILYMED
F0LZ415Z3B
Created by admin on Wed Apr 02 08:53:30 GMT 2025 , Edited by admin on Wed Apr 02 08:53:30 GMT 2025
PRIMARY
CAS
2420564-02-7
Created by admin on Wed Apr 02 08:53:30 GMT 2025 , Edited by admin on Wed Apr 02 08:53:30 GMT 2025
PRIMARY
INN
11776
Created by admin on Wed Apr 02 08:53:30 GMT 2025 , Edited by admin on Wed Apr 02 08:53:30 GMT 2025
PRIMARY
FDA UNII
F0LZ415Z3B
Created by admin on Wed Apr 02 08:53:30 GMT 2025 , Edited by admin on Wed Apr 02 08:53:30 GMT 2025
PRIMARY
SMS_ID
300000026512
Created by admin on Wed Apr 02 08:53:30 GMT 2025 , Edited by admin on Wed Apr 02 08:53:30 GMT 2025
PRIMARY
USAN
JK-66
Created by admin on Wed Apr 02 08:53:30 GMT 2025 , Edited by admin on Wed Apr 02 08:53:30 GMT 2025
PRIMARY
RXCUI
2587300
Created by admin on Wed Apr 02 08:53:30 GMT 2025 , Edited by admin on Wed Apr 02 08:53:30 GMT 2025
PRIMARY
ACTIVE MOIETY
TIXAGEVIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966